SCHEMBL288227

SCHEMBL288227

O=[N+]([O-])c1cccc(SSc2cccc([N+](=O)[O-])c2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 1.00
TSHR P16473 6/20 0.67
LMNA P02545 2/20 0.67
ALDH1A1 P00352 6/20 0.55
ACHE P22303 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
ALOX15 P16050 1/20 0.55
HTT P42858 2/20 0.52
KMT2A Q03164 2/20 0.52
GAA P10253 1/20 0.52
CES2 O00748 1/20 0.52
CES1 P23141 1/20 0.52
MEN1 O00255 1/20 0.52
DDX3X O00571 1/20 0.52
POLB P06746 1/20 0.52
MAPT P10636 1/20 0.52
CTDSP1 Q9GZU7 1/20 0.52
TP53 P04637 1/20 0.50
NFE2L2 Q16236 1/20 0.48
CA2 P00918 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31482901 1.00 HSP90AA1 (1.00) HSP90AA1TSHRLMNAALDH1A1ACHE
SCHEMBL30468119 1.00 HSP90AA1 (1.00) HSP90AA1TSHRLMNAALDH1A1ACHE
SCHEMBL4909394 0.88 HSP90AA1 (0.79) HSP90AA1TSHRLMNAALDH1A1ACHE
SCHEMBL31405188 0.87 HSP90AA1 (0.77) HSP90AA1TSHRLMNAALDH1A1ACHE
SCHEMBL11356136 0.87 HSP90AA1 (0.77) HSP90AA1TSHRLMNAALDH1A1ACHE
SCHEMBL20347051 0.87 HSP90AA1 (0.77) HSP90AA1TSHRLMNAALDH1A1ACHE
SCHEMBL1818188 0.85 HSP90AA1 (0.74) HSP90AA1TSHRLMNAALDH1A1ACHE
SCHEMBL4902082 0.84 HSP90AA1 (0.71) HSP90AA1TSHRLMNAALDH1A1ACHE
SCHEMBL4910155 0.84 HSP90AA1 (0.71) HSP90AA1TSHRLMNAALDH1A1ACHE
SCHEMBL288228 0.83 HSP90AA1 (0.71) HSP90AA1TSHRLMNAALDH1A1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 258 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2931703-B1 METHOD FOR PRODUCING BIS (3-AMINOPHENYL) DISULFIDES AND 3-AMINOTHIOLS BAYER CROPSCIENCE AG (DE) 2018-11-28 EP claimed
US-20150329485-A1 METHOD FOR PRODUCING BIS(3-AMINOPHENYL)DISULFIDES AND 3-AMINOTHIOLS BAYER CROPSCIENCE AG (DE) 2015-11-19 US claimed
EP-2931703-A1 METHOD FOR PRODUCING BIS(3-AMINOPHENYL)DISULFIDES AND 3-AMINOTHIOLS Bayer CropScience AG (DE) 2015-10-21 EP claimed
WO-2014090913-A1 METHOD FOR PRODUCING BIS(3-AMINOPHENYL)DISULFIDES AND 3-AMINOTHIOLS BAYER CROPSCIENCE AG (DE) 2014-06-19 WO claimed
US-7732534-B2 Polymers functionalized with nitro compounds BRIDGESTONE CORPORATION (JP) 2010-06-08 US claimed
US-20080051552-A1 Polymers functionalized with nitro compounds BRIDGESTONE CORPORATION 2008-02-28 US claimed
US-20080051519-A1 Polymers functionalized with nitro compounds BRIDGESTONE CORPORATION (JP) 2008-02-28 US claimed
US-6989263-B1 Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2006-01-24 US claimed
EP-1435930-A2 ANTI-GLYCATION AGENTS FOR PREVENTING AGE-, DIABETES-, AND SMOKING-RELATED COMPLICATIONS NATIONAL RESEARCH COUNCIL OF CANADA (CA) 2004-07-14 EP claimed
US-20030198648-A1 Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to HIV-1 RNA ACHILION PHARMACEUTICALS 2003-10-23 US claimed
WO-2003060098-A2 METHODS FOR IDENTIFYING COMPOUNDS WHICH INHIBIT BINDING OF NUCLEOCAPSID 7 PROTEIN TO HIV-1 RNA ACHILLION PHARMACEUTICALS, INC. (US) 2003-07-24 WO claimed
WO-2003032969-A2 ANTI-GLYCATION AGENTS FOR PREVENTING AGE-, DIABETES-, AND SMOKING-RELATED COMPLICATIONS NATIONAL RESEARCH COUNCIL OF CANADA (CA) 2003-04-24 WO claimed
EP-0782632-B1 A METHOD FOR IDENTIFYING AND USING COMPOUNDS THAT INACTIVATE HIV-1 AND OTHER RETROVIRUSES BY ATTACKING HIGHLY CONSERVED ZINC FINGERS IN THE VIRAL NUCLEOCAPSID PROTEIN US GOV HEALTH & HUMAN SERV (US) 2003-04-16 EP claimed
US-6001555-A DISSOCIATING A ZINC FINGER BY CONTACTING THE PROTEIN WITH A DISULFIDE, A MALEIMIDE, AN ALPHA-HALOGENATED KETONE, A HYDRAZIDE, A NITRIC OXIDE OR DERIVATIVES, CUPRIC IONS, FERRIC IONS OR THEIR COMPLEXES; SYNERGISTIC EFFECTS WITH VIRICIDES THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1999-12-14 US claimed
EP-0782632-A1 A METHOD FOR IDENTIFYING AND USING COMPOUNDS THAT INACTIVATE HIV-1 AND OTHER RETROVIRUSES BY ATTACKING HIGHLY CONSERVED ZINC FINGERS IN THE VIRAL NUCLEOCAPSID PROTEIN THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the Secretary of the Department of Health and Human Services (US) 1997-07-09 EP claimed
WO-1996009406-A9 A METHOD FOR IDENTIFYING AND USING COMPOUNDS THAT INACTIVATE HIV-1 AND OTHER RETROVIRUSES BY ATTACKING HIGHLY CONSERVED ZINC FINGERS IN THE VIRAL NUCLEOCAPSID PROTEIN 1996-05-23 WO claimed
WO-1996009406-A1 A METHOD FOR IDENTIFYING AND USING COMPOUNDS THAT INACTIVATE HIV-1 AND OTHER RETROVIRUSES BY ATTACKING HIGHLY CONSERVED ZINC FINGERS IN THE VIRAL NUCLEOCAPSID PROTEIN THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1996-03-28 WO claimed
EP-0693056-A1 PROCESS FOR THE PREPARATION OF ARYL- AND HETEROARYLSULPHURPENTAFLUORIDES ZENECA LIMITED (GB) 1996-01-24 EP claimed
WO-1994022817-A1 PROCESS FOR THE PREPARATION OF ARYL- AND HETEROARYLSULPHURPENTAFLUORIDES ZENECA LIMITED (GB) 1994-10-13 WO claimed
JP-56043338-A None JP disclosed
JP-1165586-A None JP disclosed
CN-116283684-B Green preparation method of diphenyl sulfide and derivative thereof 常州大学 2025-04-08 CN disclosed
US-20230278965-A1 NOVEL CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS COMPRISING 2 OR MORE ARYL OR HETEROARYL CONNECTED VIA LINKER AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2023-09-07 US disclosed
CN-116283684-A Green preparation method of diphenyl sulfide and derivative thereof 常州大学 2023-06-23 CN disclosed
CN-110845287-B Method for selective vulcanization of aliphatic amine 陕西师范大学 2023-02-14 CN disclosed
WO-2023001999-A1 C2-THIOETHER TRYPTOPHAN TRIMERS AND TETRAMERS FOR THE TREATMENT OF BETACORONOAVIRUS INFECTIONS 1. CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) (ES) 2023-01-26 WO disclosed
EP-4122917-A1 C2-THIOETHER TRYPTOPHAN TRIMERS AND TETRAMERS AND USE THEREOF Consejo Superior de Investigaciones Científicas (CSIC) (ES) 2023-01-25 EP disclosed
CN-113956521-B Preparation method of super-hydrophobic antifouling anti-drag material 中国船舶重工集团公司第七二五研究所 2022-12-13 CN disclosed
US-11500247-B2 Liquid crystal sensor PLATYPUS TECHNOLOGIES, LLC (US) 2022-11-15 US disclosed
CN-113956521-A Preparation method of super-hydrophobic antifouling anti-drag material 中国船舶重工集团公司第七二五研究所 2022-01-21 CN disclosed
CN-111116461-B Palladium-catalyzed o-toluidine amide gamma-C- (sp)3) Synthesis method of H sulfur/selenium ether compound 浙江工业大学 2021-07-27 CN disclosed
US-20200409221-A1 LIQUID CRYSTAL SENSOR PLATYPUS TECHNOLOGIES, LLC 2020-12-31 US disclosed
CN-111373077-A Sn or Sn alloy plating solution and method for producing Sn or Sn alloy plating 上村工业株式会社 2020-07-03 CN disclosed
US-20200208285-A1 ELECTROLYTIC SN OR SN ALLOY PLATING SOLUTION AND METHOD FOR PRODUCING SN OR SN ALLOY PLATED ARTICLE UEMURA KOGYO KK (JP) 2020-07-02 US disclosed
CN-111116461-A Palladium-catalyzed o-toluidine amide gamma-C- (sp)3) Synthesis method of H sulfur/selenium ether compound 浙江工业大学 2020-05-08 CN disclosed
CN-110845287-A Method for selective vulcanization of aliphatic amine 陕西师范大学 2020-02-28 CN disclosed
US-10239831-B2 Method for producing bis(3-aminophenyl)disulfides and 3-aminothiols BAYER CROPSCIENCE AG (DE) 2019-03-26 US disclosed
EP-2931703-B1 METHOD FOR PRODUCING BIS (3-AMINOPHENYL) DISULFIDES AND 3-AMINOTHIOLS BAYER CROPSCIENCE AG (DE) 2018-11-28 EP disclosed
US-20180258036-A1 METHOD FOR PRODUCING BIS(3-AMINOPHENYL)DISULFIDES AND 3-AMINOTHIOLS BAYER CROPSCIENCE AG (DE) 2018-09-13 US disclosed
US-10053421-B2 Method for producing bis(3-aminophenyl)disulfides and 3-aminothiols BAYER CROPSCIENCE AG (DE) 2018-08-21 US disclosed
US-9949480-B2 N-alkylthio beta-lactams, alkyl-coenzyme A asymmetric disulfides, and aryl-alkyl disulfides as anti-bacterial agents UNIVERSITY OF SOUTH FLORIDA (US) 2018-04-24 US disclosed
US-20170212088-A1 DETECTION OF GAS-PHASE ANALYTES USING LIQUID CRYSTALS PLATYPUS TECHNOLOGIES, LLC 2017-07-27 US disclosed
US-9575037-B2 Detection of gas-phase analytes using liquid crystals PLATYPUS TECHNOLOGIES, LLC (US) 2017-02-21 US disclosed
EP-2805940-B1 PYRAZINE CARBOXAMIDE COMPOUND ASTELLAS PHARMA INC (JP) 2016-11-23 EP disclosed
US-20160274084-A1 DETECTION OF VAPOR PHASE COMPOUNDS BY CHANGES IN PHYSICAL PROPERTIES OF A LIQUID CRYSTAL PLATYPUS TECHNOLOGIES, LLC 2016-09-22 US disclosed
US-20160160178-A1 IMMUNOTHERAPY USING STEM CELLS WHITE OAK IND INC (US) 2016-06-09 US disclosed
US-9341576-B2 Detection of vapor phase compounds by changes in physical properties of a liquid crystal PLATYPUS TECHNOLOGIES, LLC (US) 2016-05-17 US disclosed
US-20160018371-A1 DETECTION OF GAS-PHASE ANALYTES USING LIQUID CRYSTALS PLATYPUS TECHNOLOGIES, LLC 2016-01-21 US disclosed
US-20150327547-A1 N-ALKYLTHIO BETA-LACTAMS, ALKYL-COENZYME A ASYMMETRIC DISULFIDES, AND ARYL-ALKYL DISULFIDES AS ANTI-BACTERIAL AGENTS UNIVERSITY OF SOUTH FLORIDA (US) 2015-11-19 US disclosed
US-20150329485-A1 METHOD FOR PRODUCING BIS(3-AMINOPHENYL)DISULFIDES AND 3-AMINOTHIOLS BAYER CROPSCIENCE AG (DE) 2015-11-19 US disclosed
US-20150329485-A1 METHOD FOR PRODUCING BIS(3-AMINOPHENYL)DISULFIDES AND 3-AMINOTHIOLS BAYER CROPSCIENCE AG (DE) 2015-11-19 US disclosed
EP-2931703-A1 METHOD FOR PRODUCING BIS(3-AMINOPHENYL)DISULFIDES AND 3-AMINOTHIOLS Bayer CropScience AG (DE) 2015-10-21 EP disclosed
US-9096635-B2 N-alkylthio beta-lactams, alkyl-coenzyme A asymmetric disulfides, and aryl-alkyl disulfides as anti-bacterial agents UNIVERSITY OF SOUTH FLORIDA (US) 2015-08-04 US disclosed
US-9085540-B2 Pyrazinecarboxamide compound ASTELLAS PHARMA INC. (JP) 2015-07-21 US disclosed
US-20150125489-A1 METHOD FOR THE PREPARATION OF DENDRITIC CELL VACCINES LABORATORIOS DEL DR. ESTEVE S.A. (ES) 2015-05-07 US disclosed
CN-104530007-A Preparation method of mono-substituted carbazolyl sulfide compound UNIV HUNAN 2015-04-22 CN disclosed
EP-2819696-A1 METHOD FOR THE PREPARATION OF DENDRITIC CELL VACCINES Laboratorios Del. Dr. Esteve, S.A. (ES) 2015-01-07 EP disclosed
EP-2805940-A1 PYRAZINE CARBOXAMIDE COMPOUND Astellas Pharma Inc. (JP) 2014-11-26 EP disclosed
US-20140323463-A1 PYRAZINECARBOXAMIDE COMPOUND ASTELLAS PHARMA INC. (JP) 2014-10-30 US disclosed
WO-2014165196-A1 DETECTION OF GAS-PHASE ANALYTES USING LIQUID CRYSTALS PLATYPUS TECHNOLOGIES, LLC (US) 2014-10-09 WO disclosed
CN-104080774-A Pyrazine carboxamide compound ASTELLAS PHARMA INC 2014-10-01 CN disclosed
US-20140235565-A1 N-ALKYLTHIO BETA-LACTAMS, ALKYL-COENZYME A ASYMMETRIC DISULFIDES, AND ARYL-ALKYL DISULFIDES AS ANTI-BACTERIAL AGENTS UNIVERSITY OF SOUTH FLORIDA (US) 2014-08-21 US disclosed
WO-2014090913-A1 METHOD FOR PRODUCING BIS(3-AMINOPHENYL)DISULFIDES AND 3-AMINOTHIOLS BAYER CROPSCIENCE AG (DE) 2014-06-19 WO disclosed
US-8722937-B2 Asymmetric disulfides and aryl-alkyl disulfides as anti-bacterial agents UNIVERSITY OF SOUTH FLORIDA (US) 2014-05-13 US disclosed
WO-2013127976-A1 METHOD FOR THE PREPARATION OF DENDRITIC CELL VACCINES LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2013-09-06 WO disclosed
US-20120288951-A1 DETECTION OF VAPOR PHASE COMPOUNDS BY CHANGES IN PHYSICAL PROPERTIES OF A LIQUID CRYSTAL PLATYPUS TECHNOLOGIES, LLC (US) 2012-11-15 US disclosed
US-20120122860-A1 SOLID FORMS OF SULFONAMIDES AND AMINO ACIDS PLEXXIKON, INC. 2012-05-17 US disclosed
US-20120122860-A1 SOLID FORMS OF SULFONAMIDES AND AMINO ACIDS PLEXXIKON, INC. 2012-05-17 US disclosed
US-20120122860-A1 SOLID FORMS OF SULFONAMIDES AND AMINO ACIDS PLEXXIKON, INC. 2012-05-17 US disclosed
US-8178355-B2 Detection of vapor phase compounds by changes in physical properties of a liquid crystal PLATYPUS TECHNOLOGIES, LLC. (US) 2012-05-15 US disclosed
EP-2427433-A1 SOLID FORMS OF SULFONAMIDES AND AMINO ACIDS Plexxikon, Inc. (US) 2012-03-14 EP disclosed
EP-2344879-A2 DETECTION OF VAPOR PHASE COMPOUNDS BY CHANGES IN PHYSICAL PROPERTIES OF A LIQUID CRYSTAL Platypus Technologies, LLC (US) 2011-07-20 EP disclosed
US-7871982-B2 Lincomycin derivatives and antimicrobial agents comprising the same as active ingredient MEIJI SEIKA KAISHA, LTD. (JP) 2011-01-18 US disclosed
US-7833331-B2 Non-toxic corrosion-protection pigments based on cobalt UNIVERSITY OF DAYTON (US) 2010-11-16 US disclosed
WO-2010129570-A1 SOLID FORMS OF SULFONAMIDES AND AMINO ACIDS PLEXXIKON, INC. (US) 2010-11-11 WO disclosed
WO-2010129570-A1 SOLID FORMS OF SULFONAMIDES AND AMINO ACIDS PLEXXIKON, INC. (US) 2010-11-11 WO disclosed
EP-1225205-B1 Carbon black reacted with diazonium salts and products CABOT CORP (US) 2010-10-06 EP disclosed
US-7789958-B2 Non-toxic corrosion-protection pigments based on manganese UNIVERSITY OF DAYTON (US) 2010-09-07 US disclosed
US-20100144698-A1 SUBSTITUTED AZETIDINONES DAIAMED (US) 2010-06-10 US disclosed
US-20100144698-A1 SUBSTITUTED AZETIDINONES DAIAMED (US) 2010-06-10 US disclosed
US-20100144698-A1 SUBSTITUTED AZETIDINONES DAIAMED (US) 2010-06-10 US disclosed
US-7732534-B2 Polymers functionalized with nitro compounds BRIDGESTONE CORPORATION (JP) 2010-06-08 US disclosed
US-20100093096-A1 DETECTION OF VAPOR PHASE COMPOUNDS BY CHANGES IN PHYSICAL PROPERTIES OF A LIQUID CRYSTAL PLATYPUS TECHNOLOGIES, LLC (US) 2010-04-15 US disclosed
EP-1942156-B1 Carbon black reacted with diazonium salts and products CABOT CORP (US) 2010-04-14 EP disclosed
WO-2010031047-A2 DETECTION OF VAPOR PHASE COMPOUNDS BY CHANGES IN PHYSICAL PROPERTIES OF A LIQUID CRYSTAL PLATYPUS TECHNOLOGIES, LLC (US) 2010-03-18 WO disclosed
US-7626027-B2 Substituted 1H-pyrrolo[2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase Iε AVENTIS PHARMACEUTICALS INC (US) 2009-12-01 US disclosed
US-20090163628-A1 NON-TOXIC CORROSION-PROTECTION PIGMENTS BASED ON COBALT STURGILL JEFFREY ALLEN 2009-06-25 US disclosed
US-20090156512-A1 potent activity against resistant pneumococci MEIJI SEIKA KAISHA, LTD. (JP) 2009-06-18 US disclosed
US-20090143351-A1 SUBSTITUTED AZETIDINONES DAIAMED (US) 2009-06-04 US disclosed
US-20090143351-A1 SUBSTITUTED AZETIDINONES DAIAMED (US) 2009-06-04 US disclosed
US-20090143351-A1 SUBSTITUTED AZETIDINONES DAIAMED (US) 2009-06-04 US disclosed
US-7541008-B2 Fluid reactor UNIVERSITY OF DURHAM OF UNIVERSITY OFFICE (GB) 2009-06-02 US disclosed
US-7541008-B2 Fluid reactor UNIVERSITY OF DURHAM OF UNIVERSITY OFFICE (GB) 2009-06-02 US disclosed
US-7541008-B2 Fluid reactor UNIVERSITY OF DURHAM OF UNIVERSITY OFFICE (GB) 2009-06-02 US disclosed
EP-1747220-B1 SUBSTITUTED 1H-PYRROLO[3,2-B, 3,2-C, AND 2,3-C]PYRIDINE-2-CARBOXAMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE I EPSILON AVENTIS PHARMA INC (US) 2009-04-15 EP disclosed
US-7501404-B2 Substituted azetidinones DAIMED (US) 2009-03-10 US disclosed
US-7501404-B2 Substituted azetidinones DAIMED (US) 2009-03-10 US disclosed
US-7501404-B2 Substituted azetidinones DAIMED (US) 2009-03-10 US disclosed
EP-1809602-B1 INDOLE DERIVATIVES USEFUL AS PROGESTERONE RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2008-10-29 EP disclosed
EP-1970377-A1 LINCOMYCIN DERIVATIVE AND ANTIBACTERIAL AGENT CONTAINING THE SAME AS ACTIVE INGREDIENT MEIJI SEIKA KAISHA LTD. (JP) 2008-09-17 EP disclosed
US-7422793-B2 Non-toxic corrosion-protection rinses and seals based on rare earth elements UNIVERSITY OF DAYTON (US) 2008-09-09 US disclosed
US-20080200496-A1 SUBSTITUTED 1H-PYRROLO[3,2-b, 3,2-c, and 2,3-c]PYRIDINE-2-CARBOXAMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE Ie AVENTIS PHARMACEUTICALS INC. (US) 2008-08-21 US disclosed
US-7407711-B2 Non-toxic corrosion-protection conversion coats based on rare earth elements UNIVERSITY OF DAYTON (US) 2008-08-05 US disclosed
US-20080182815-A1 Act against several infective agents, and most notably Bacillus spp. and Staphylococcus spp., including infection caused by methicillin-resistant Staphylococcus aureus (MRSA) UNIVERSITY OF SOUTH FLORIDA 2008-07-31 US disclosed
US-7402672-B2 Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase lepsilon AVENTIS PHARMACEUTICALS INC. (US) 2008-07-22 US disclosed
EP-1942156-A1 Carbon black reacted with diazonium salts and products Cabot Corporation (US) 2008-07-09 EP disclosed
US-20080139664-A1 ANTI-GLYCATION AGENTS FOR PREVENTING AGE-, DIABETES-, AND SMOKING-RELATED COMPLICATIONS NATIONAL RESEARCH COUNCIL OF CANADA (CA) 2008-06-12 US disclosed
US-20080099112-A1 Reduced sensitivity melt-pourable Tritonal replacements ALLIANT TECHSYSTEMS INC. 2008-05-01 US disclosed
US-7345084-B2 Indole derivatives useful as progesterone receptor modulators JANSSEN PHARMACEUTICA N.V. (BE) 2008-03-18 US disclosed
US-20080051552-A1 Polymers functionalized with nitro compounds BRIDGESTONE CORPORATION 2008-02-28 US disclosed
US-20080051519-A1 Polymers functionalized with nitro compounds BRIDGESTONE CORPORATION (JP) 2008-02-28 US disclosed
EP-1879900-A2 SULFOXIMINE-PYRIMIDINE MACROCYCLES AND THE SALTS THEREOF, A PROCESS FOR MAKING THEM, AND THEIR PHARMACEUTICAL USE AGAINST CANCER Bayer Schering Pharma Aktiengesellschaft (DE) 2008-01-23 EP disclosed
EP-1011729-B1 OLIGONUCLEOTIDES WHICH SPECIFICALLY BIND RETROVIRAL NUCLEOCAPSID PROTEINS US GOV HEALTH & HUMAN SERV (US) 2008-01-09 EP disclosed
EP-1871741-A2 SUBSTITUTED AZETIDINONES Daiamed, Inc. (US) 2008-01-02 EP disclosed
US-7294211-B2 Non-toxic corrosion-protection conversion coats based on cobalt UNIVERSITY OF DAYTON (US) 2007-11-13 US disclosed
US-7294185-B2 In absence of exterior applies electrical current; wear resistance CABOT CORPORATION (US) 2007-11-13 US disclosed
US-7291217-B2 Non-toxic corrosion-protection pigments based on rare earth elements UNIVERSITY OF DAYTON (US) 2007-11-06 US disclosed
EP-1809602-A1 INDOLE DERIVATIVES USEFUL AS PROGESTERONE RECEPTOR MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-25 EP disclosed
US-20070149673-A1 NON-TOXIC CORROSION-PROTECTION PIGMENTS BASED ON MANGANESE STURGILL JEFFREY A 2007-06-28 US disclosed
US-7235142-B2 Non-toxic corrosion-protection rinses and seals based on cobalt UNIVERSITY OF DAYTON (US) 2007-06-26 US disclosed
US-20070135511-A1 INDOLE DERIVATIVES USEFUL AS PROGESTERONE RECEPTOR MODULATORS JIANG WEIQIN 2007-06-14 US disclosed
US-20070105832-A1 Substituted azetidinones Cadrenal Therapeutics, Inc. 2007-05-10 US disclosed
US-20070105832-A1 Substituted azetidinones Cadrenal Therapeutics, Inc. 2007-05-10 US disclosed
US-20070105832-A1 Substituted azetidinones Cadrenal Therapeutics, Inc. 2007-05-10 US disclosed
US-7183309-B2 Indole derivatives useful as progesterone receptor modulators JANSSEN PHARMACEUTICA N.V. (BE) 2007-02-27 US disclosed
EP-1747220-A1 SUBSTITUTED 1H-PYRROLO 3,2-B, 3,2-C, AND 2,3-C¨PYRIDINE-2-CARBOXAMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE I EPSILON Aventis Pharmaceuticals Inc. (US) 2007-01-31 EP disclosed
US-20060252782-A1 Sulfoximine-macrocycle compounds and salts thereof, pharmaceutical compositions comprising said compounds, methods of preparing same and uses of same SCHERING AKTIENGESELLSCHAFT (DE) 2006-11-09 US disclosed
WO-2006108695-A2 SULFOXIMINE-PYRIMIDINE MACROCYCLES AND THE SALTS THEREOF , A PROCESS FOR MAKING THEM, AND THEIR PHARMACEUTICAL USE AGAINST CANCER BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2006-10-19 WO disclosed
WO-2006108039-A2 SUBSTITUTED AZETIDINONES DAIAMED, INC. (US) 2006-10-12 WO disclosed
EP-1710246-A1 Sulfoximine-pyrimidine Macrocycles and the salts thereof, a process for making them, and their pharmaceutical use against cancer Schering Aktiengesellschaft (DE) 2006-10-11 EP disclosed
US-7101676-B2 Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to HIV-1 RNA ACHILION PHARMACEUTICALS 2006-09-05 US disclosed
US-7067024-B2 Reduced sensitivity, melt-pourable TNT replacements ALLIANT TECHSYSTEMS INC. (US) 2006-06-27 US disclosed
US-20060111427-A1 Indole derivatives useful as progesterone receptor modulators JANSSEN PHARMACEUTICA N.V. (BE) 2006-05-25 US disclosed
WO-2006049889-A1 INDOLE DERIVATIVES USEFUL AS PROGESTERONE RECEPTOR MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2006-05-11 WO disclosed
EP-0799281-B2 CARBON BLACK REACTED WITH DIAZONIUM SALTS AND PRODUCTS CABOT CORP (US) 2006-03-29 EP disclosed
US-6989263-B1 Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2006-01-24 US disclosed
US-6984644-B2 Treatment of skin disorders using thieno[2,3-D]pyrimidinediones ASTRAZENECA AB (SE) 2006-01-10 US disclosed
US-6964714-B2 Reduced sensitivity, melt-pourable tritonal replacements ALLIANT TECHSYSTEMS INC. (US) 2005-11-15 US disclosed
US-6960688-B2 Use of compounds for the elevation of pyruvate dehydrogenase activity ASTRAZENECA AB (SE) 2005-11-01 US disclosed
US-20050214184-A1 Fluid reactor UNIVERSITY OF DURHAM OF UNIVERSITY OFFICE (GB) 2005-09-29 US disclosed
US-6943268-B2 Method for induction of L-selectin shedding SCIENCE & TECHNOLOGY CORPORATION @ UNM (US) 2005-09-13 US disclosed
WO-2005061498-A1 SUBSTITUTED 1H-PYRROLO[3,2-B, 3,2-C, AND 2,3-C]PYRIDINE-2-CARBOXAMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE I EPSILON AVENTIS PHARMACEUTICALS INC. (US) 2005-07-07 WO disclosed
US-20050131012-A1 Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase lepsilon AVENTIS PHARMACEUTICALS INC. (US) 2005-06-16 US disclosed
US-20050043408-A1 Anti-glycation agents for preventing age- diabetes- and smoking-related complications NATIONAL RESEARCH COUNCIL OF CANADA (CA) 2005-02-24 US disclosed
US-20050034629-A1 In absence of exterior applies electrical current; wear resistance BELMONT JAMES A (US) 2005-02-17 US disclosed
EP-1472319-A1 NON-TOXIC CORROSION PROTECTION PIGMENTS BASED ON COBALT UNIVERSITY OF DAYTON (US) 2004-11-03 EP disclosed
WO-2004065305-A1 NON-TOXIC CORROSION-PROTECTION PIGMENTS BASED ON MANGANESE UNIVERSITY OF DAYTON (US) 2004-08-05 WO disclosed
EP-1435930-A2 ANTI-GLYCATION AGENTS FOR PREVENTING AGE-, DIABETES-, AND SMOKING-RELATED COMPLICATIONS NATIONAL RESEARCH COUNCIL OF CANADA (CA) 2004-07-14 EP disclosed
US-20040104377-A1 Non-toxic corrosion-protection pigments based on rare earth elements UNIVERSITY OF DAYTON 2004-06-03 US disclosed
US-6740151-B2 IN THE ABSENCE OF AN EXTERNALLY APPLIED ELECTRIC CURRENT SUFFICIENT TO REDUCE THE DIAZONIUM SALT AND ATTACH AN ORGANIC GROUP; IMPROVED ABRASION RESISTANCE. CABOT CORPORATION 2004-05-25 US disclosed
EP-1399400-A1 REDUCED SENSITIVITY, MELT-POURABLE TNT REPLACEMENTS ALLIANT TECHSYSTEMS INC. (US) 2004-03-24 EP disclosed
EP-1399399-A1 REDUCED SENSITIVITY, MELT-POURABLE TRITONAL REPLACEMENTS ALLIANT TECHSYSTEMS INC. (US) 2004-03-24 EP disclosed
EP-1082110-B1 USE OF COMPOUNDS FOR THE ELEVATION OF PYRUVATE DEHYDROGENASE ACTIVITY ASTRAZENECA AB (SE) 2004-03-24 EP disclosed
US-20040020568-A1 Non-toxic corrosion-protection conversion coats based on rare earth elements DAYTON, UNIVERSITY OF 2004-02-05 US disclosed
WO-2004009114-A1 METHOD FOR DISCOVERING SUBSTANCES FOR INHIBITING ENZYMES PHARMACIA & UPJOHN COMPANY (US) 2004-01-29 WO disclosed
US-20040016910-A1 Non-toxic corrosion-protection rinses and seals based on rare earth elements DAYTON, UNIVERSITY OF 2004-01-29 US disclosed
US-20040018581-A1 Method for discovering substances for inhibiting enzymes PHARMACIA AND UPJOHN COMPANY 2004-01-29 US disclosed
US-20040011252-A1 Non-toxic corrosion-protection pigments based on manganese UNIVERSITY OF DAYTON 2004-01-22 US disclosed
US-20040009979-A1 Use of compounds for the elevation of pyruvate dehydrogenase activity ZENECA LIMITED 2004-01-15 US disclosed
US-20030234063-A1 Non-toxic corrosion-protection conversion coats based on cobalt DAYTON, UNIVERSITY OF 2003-12-25 US disclosed
US-20030230363-A1 Non-toxic corrosion-protection rinses and seals based on cobalt UNIVERSITY OF DAYTON 2003-12-18 US disclosed
WO-2003095086-A2 FLUID REACTOR THE UNIVERSITY OF DURHAM (GB) 2003-11-20 WO disclosed
US-20030198648-A1 Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to HIV-1 RNA ACHILION PHARMACEUTICALS 2003-10-23 US disclosed
US-20030191142-A1 Thieno[2,3-d]pyrimidinediones, their preparation and use in therapy ASTRAZENECA AB 2003-10-09 US disclosed
US-20030140993-A1 Reduced sensitivity, melt-pourable tritonal replacements NORTHROP GRUMMAN SYSTEMS CORPORATION 2003-07-31 US disclosed
WO-2003060191-A2 NON-TOXIC CORROSION-PROTECTION CONVERSION COATINGES ABSED ON COBALT UNIVERSITY OF DAYTON (US) 2003-07-24 WO disclosed
WO-2003060192-A1 NON-TOXIC CORROSION-PROTECTION RINSES AND SEALS BASED ON COBALT UNIVERSITY OF DAYTON (US) 2003-07-24 WO disclosed
WO-2003060098-A2 METHODS FOR IDENTIFYING COMPOUNDS WHICH INHIBIT BINDING OF NUCLEOCAPSID 7 PROTEIN TO HIV-1 RNA ACHILLION PHARMACEUTICALS, INC. (US) 2003-07-24 WO disclosed
WO-2003060019-A1 NON-TOXIC CORROSION PROTECTION PIGMENTS BASED ON COBALT UNIVERSITY OF DAYTON (US) 2003-07-24 WO disclosed
US-20030095914-A1 In the absence of an externally applied electric current sufficient to reduce the diazonium salt and attach an organic group; improved abrasion resistance. BELMONT JAMES A (US) 2003-05-22 US disclosed
US-20030092763-A1 Method for induction of L-selectin shedding SCIENCE & TECHNOLOGY CORPORATION @UNM 2003-05-15 US disclosed
WO-2003032969-A2 ANTI-GLYCATION AGENTS FOR PREVENTING AGE-, DIABETES-, AND SMOKING-RELATED COMPLICATIONS NATIONAL RESEARCH COUNCIL OF CANADA (CA) 2003-04-24 WO disclosed
EP-0782632-B1 A METHOD FOR IDENTIFYING AND USING COMPOUNDS THAT INACTIVATE HIV-1 AND OTHER RETROVIRUSES BY ATTACKING HIGHLY CONSERVED ZINC FINGERS IN THE VIRAL NUCLEOCAPSID PROTEIN US GOV HEALTH & HUMAN SERV (US) 2003-04-16 EP disclosed
WO-2003002486-A1 REDUCED SENSITIVITY, MELT-POURABLE TNT REPLACEMENTS ALLIANT TECHSYSTEMS INC. (US) 2003-01-09 WO disclosed
WO-2003002485-A1 REDUCED SENSITIVITY, MELT-POURABLE TRITONAL REPLACEMENTS ALLIANT TECHSYSTEMS INC. (US) 2003-01-09 WO disclosed
US-20030005988-A1 Reduced sensitivity, melt-pourable TNT replacements NORTHROP GRUMMAN SYSTEMS CORPORATION 2003-01-09 US disclosed
US-6498275-B1 Use of compounds for the elevation of pyruvate dehydrogenase activity ASTRAZENECA AB (SE) 2002-12-24 US disclosed
US-6498189-B1 SUPPRESSION OF INFLAMMATION AND OF LYMPH NODE ENTRY BY CALMODULIN ANTAGONISTS; CELL ASSOCIATED PROTEIN DISULFIDE ISOMERASE INHIBITORS; P-AMINOPHENYLARSINE OXIDES UNIVERSITY OF NEW MEXICO 2002-12-24 US disclosed
US-6494946-B1 PROCESSES FOR PREPARING A CARBON BLACK PRODUCT HAVING AN ORGANIC GROUP ATTACHED TO THE CARBON BLACK. IN ONE PROCESS AT LEAST ONE DIAZONIUM SALT REACTS WITH A CARBON BLACK IN THE ABSENCE OF AN EXTERNALLY APPLIED ELECTRIC CURRENT SUFFICIENT CABOT CORPORATION 2002-12-17 US disclosed
US-20020183337-A1 For use in immunosuppression; for reducing the risk of, a reversible obstructive airways disease ASTRAZENECA AB. 2002-12-05 US disclosed
US-6469014-B1 IMMUNOSUPPRESSIVE ACTIVITY ASTRAZENECA AB (SE) 2002-10-22 US disclosed
EP-0991653-B1 NOVEL COMPOUNDS ASTRAZENECA AB (SE) 2002-10-16 EP disclosed
US-6432294-B1 ELECTROCHEMICAL OXIDATION OF DISULFIDES IN ARENE SOLUTIONS FOR SYNTHESIS OF ORGANOTHIATED PRODUCT THE UNIVERSITY OF ARIZONA 2002-08-13 US disclosed
EP-0799281-B1 CARBON BLACK REACTED WITH DIAZONIUM SALTS AND PRODUCTS CABOT CORP (US) 2002-07-24 EP disclosed
EP-1225205-A2 Carbon black reacted with diazonium salts and products CABOT CORPORATION (US) 2002-07-24 EP disclosed
US-6342502-B1 ANTIASTHMATICS ASTRAZENECA AB (GB) 2002-01-29 US disclosed
US-6316190-B1 FOR DETECTING OR PURIFYING HUMAN IMMUNODEFICIENCY VIRUS(HIV) FROM BLOOD SAMPLE THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES 2001-11-13 US disclosed
CN-1303281-A Application of compound in enhancing activity of pyruvate dehydrogenase ASTRA ZENECA LTD (SE) 2001-07-11 CN disclosed
US-6207838-B1 ELECTROLYSIS IN LIQUID SULFUR DIOXIDE THE UNIVERSITY OF ARIZONA 2001-03-27 US disclosed
EP-1082110-A1 USE OF COMPOUNDS FOR THE ELEVATION OF PYRUVATE DEHYDROGENASE ACTIVITY AstraZeneca AB (SE) 2001-03-14 EP disclosed
US-6180635-B1 NOVEL THIENO(2,3-D)PYRIMIDINEDIONES WHICH EXHIBIT PHARMACOLOGICAL ACTIVITY, IN PARTICULAR IMMUNOSUPPRESSIVE ACTIVITY; TREATING ALLOGRAFT REJECTION ASTRAZENECA UK LIMITED (GB) 2001-01-30 US disclosed
EP-1048752-A2 Electrochemically generated organothiating reagents and their use ALBEMARLE CORPORATION (US) 2000-11-02 EP disclosed
EP-1011729-A2 OLIGONUCLEOTIDES WHICH SPECIFICALLY BIND RETROVIRAL NUCLEOCAPSID PROTEINS THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2000-06-28 EP disclosed
EP-0991653-A1 NOVEL COMPOUNDS Astra Pharmaceuticals Limited (GB) 2000-04-12 EP disclosed
US-6042643-A AS PIGMENT TO COLOR PLASTICS, PAPER, TEXTILE, RUBBER, AQUEOUS INKS CABOT CORPORATION (US) 2000-03-28 US disclosed
EP-0590885-B1 Antibiotic carbapenem compounds ZENECA LTD (GB) 2000-03-15 EP disclosed
US-6001555-A DISSOCIATING A ZINC FINGER BY CONTACTING THE PROTEIN WITH A DISULFIDE, A MALEIMIDE, AN ALPHA-HALOGENATED KETONE, A HYDRAZIDE, A NITRIC OXIDE OR DERIVATIVES, CUPRIC IONS, FERRIC IONS OR THEIR COMPLEXES; SYNERGISTIC EFFECTS WITH VIRICIDES THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1999-12-14 US disclosed
WO-1999062506-A1 USE OF COMPOUNDS FOR THE ELEVATION OF PYRUVATE DEHYDROGENASE ACTIVITY ASTRAZENECA AB (SE) 1999-12-09 WO disclosed
EP-0784614-B1 THE PREPARATION OF FLUORINATED ORGANIC COMPOUNDS F2 CHEMICALS LIMITED (GB) 1999-10-06 EP disclosed
US-5900029-A COLORING FIBER OR TEXTILE CABOT CORPORATION (US) 1999-05-04 US disclosed
US-5851280-A Reaction of carbon black with diazonium salts, resultant carbon black products and their uses CABOT CORPORATION (US) 1998-12-22 US disclosed
WO-1998054190-A1 NOVEL COMPOUNDS ASTRA PHARMACEUTICALS LTD. (GB) 1998-12-03 WO disclosed
US-5821263-A ANTICARCINOGENIC AGENT; CHARACTERIZED BY C3' NITROGEN BEARING ONE OR TWO SULFUR SUBSTITUENTS BRISTOL-MYERS SQUIBB COMPANY (US) 1998-10-13 US disclosed
US-5741935-A Preparation of organic pentafluorosulphur compounds BRITISH NUCLEAR FUELS PLC (GB) 1998-04-21 US disclosed
WO-1998008833-A1 SULFENAMIDE TAXANE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 1998-03-05 WO disclosed
WO-1997044064-A2 OLIGONUCLEOTIDES WHICH SPECIFICALLY BIND RETROVIRAL NUCLEOCAPSID PROTEINS THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1997-11-27 WO disclosed
EP-0799281-A1 CARBON BLACK REACTED WITH DIAZONIUM SALTS AND PRODUCTS CABOT CORPORATION (US) 1997-10-08 EP disclosed
US-5663164-A CEPHALOSPORIN ANTIBIOTICS AS BACTERICIDES ROUSSEL UCLAF (FR) 1997-09-02 US disclosed
EP-0784614-A1 THE PREPARATION OF FLUORINATED ORGANIC COMPOUNDS British Nuclear Fuels PLC (GB) 1997-07-23 EP disclosed
EP-0782632-A1 A METHOD FOR IDENTIFYING AND USING COMPOUNDS THAT INACTIVATE HIV-1 AND OTHER RETROVIRUSES BY ATTACKING HIGHLY CONSERVED ZINC FINGERS IN THE VIRAL NUCLEOCAPSID PROTEIN THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the Secretary of the Department of Health and Human Services (US) 1997-07-09 EP disclosed
WO-1997005106-A1 THE PREPARATION OF FLUORINATED ORGANIC COMPOUNDS BRITISH NUCLEAR FUELS PLC (GB) 1997-02-13 WO disclosed
WO-1996018688-A1 CARBON BLACK REACTED WITH DIAZONIUM SALTS AND PRODUCTS CABOT CORPORATION (US) 1996-06-20 WO disclosed
US-5527791-A Carbapenem antibiotic compounds ZENECA LIMITED (GB) 1996-06-18 US disclosed
WO-1996009406-A9 A METHOD FOR IDENTIFYING AND USING COMPOUNDS THAT INACTIVATE HIV-1 AND OTHER RETROVIRUSES BY ATTACKING HIGHLY CONSERVED ZINC FINGERS IN THE VIRAL NUCLEOCAPSID PROTEIN 1996-05-23 WO disclosed
WO-1996009406-A1 A METHOD FOR IDENTIFYING AND USING COMPOUNDS THAT INACTIVATE HIV-1 AND OTHER RETROVIRUSES BY ATTACKING HIGHLY CONSERVED ZINC FINGERS IN THE VIRAL NUCLEOCAPSID PROTEIN THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1996-03-28 WO disclosed
EP-0693056-A1 PROCESS FOR THE PREPARATION OF ARYL- AND HETEROARYLSULPHURPENTAFLUORIDES ZENECA LIMITED (GB) 1996-01-24 EP disclosed
EP-0489360-B1 Water-soluble azocompounds, process for their preparation and their use as dyes HOECHST AG (DE) 1995-09-20 EP disclosed
WO-1994022817-A1 PROCESS FOR THE PREPARATION OF ARYL- AND HETEROARYLSULPHURPENTAFLUORIDES ZENECA LIMITED (GB) 1994-10-13 WO disclosed
EP-0590885-A1 Antibiotic carbapenem compounds ZENECA LIMITED (GB) 1994-04-06 EP disclosed
US-5300633-A Lightfast, washfast HOECHST AKTIENGESELLSCHAFT (DE) 1994-04-05 US disclosed
US-5216138-A With vinyl sulfonyl group HOECHST AKTIENGESELLSCHAFT (DE) 1993-06-01 US disclosed
EP-0513657-A2 Water-soluble azo compounds, process for their preparation and their use as dyes HOECHST AKTIENGESELLSCHAFT (DE) 1992-11-19 EP disclosed
EP-0489360-A1 Water-soluble azocompounds, process for their preparation and their use as dyes HOECHST AKTIENGESELLSCHAFT (DE) 1992-06-10 EP disclosed
CN-1034012-A A kind of synthesis method of reactive blue dye DALIAN POLYTECHNICAL COLLEGE (CN) 1989-07-19 CN disclosed
JP-H01165586-A ANTI TUMOR PRODRUG BRISTOL MYERS CO 1989-06-29 JP disclosed
EP-0317956-A2 Anti-tumor prodrugs Bristol-Myers Squibb Company (US) 1989-05-31 EP disclosed
US-4826851-A 2-substituted ergoline urea and thio-urea derivatives having neurolyptic/dopaminergic activity SCHERING AKTIENGESELLSCHAFT (DE) 1989-05-02 US disclosed
EP-0217735-A2 2-Substituted ergoline derivatives SCHERING AKTIENGESELLSCHAFT (DE) 1987-04-08 EP disclosed
US-4656290-A Process for preparing thio, dithio or carbonyl compounds CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT. (HU) 1987-04-07 US disclosed
EP-0150026-A2 Chemical process CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. (HU) 1985-07-31 EP disclosed
US-4504568-A Sensitive silver halide photothermographic materials for producing dye images EASTMAN KODAK COMPANY (US) 1985-03-12 US disclosed
EP-0025339-B1 MICROBICIDAL SULFONES, COMPOSITIONS THEREOF AND METHODS OF PREPARING THEM UNIROYAL, INC. (US) 1984-05-30 EP disclosed
EP-0093363-A1 Process for the preparation of disulphides CASSELLA Aktiengesellschaft (DE) 1983-11-09 EP disclosed
EP-0086774-A1 TREATMENT OF COCCIDIAL INFECTIONS WITH AMIDINOUREA OR AMIDINOTHIOUREA DERIVATIVES RORER INTERNATIONAL (OVERSEAS) INC. (US) 1983-08-31 EP disclosed
WO-1983000625-A1 TREATMENT OF COCCIDIAL INFECTIONS WITH AMIDINOUREA OR AMIDINOTHIOUREA DERIVATIVES STUDT, WILLIAM, LYON 1983-03-03 WO disclosed
US-4335142-A MICROBIOCIDES UNIROYAL, INC. (US) 1982-06-15 US disclosed
EP-0035393-A1 Poultry feeds containing and methods of using anovulatory compounds, and novel anovulatory imidazolines MERCK & CO. INC. (US) 1981-09-09 EP disclosed
US-4287201-A CONTAINING A 2-(SUBSTITUTED PHENYLIMINO)IMIDAZOLIDINE COMPOUND MERCK & CO., INC. (US) 1981-09-01 US disclosed
US-4286964-A Polyfunctional epoxides and halohydrins used as bridging groups to bind aromatic amine group-containing alcohols and thiols to hydroxyl bearing substrates SEED BRIAN S 1981-09-01 US disclosed
JP-S5643338-A SCORCH RETARDER FOR HALOGEN-CONTAINING POLYMER RUBBER AND PREVENTION OF SCORCH OF SAID RUBBER SANSHIN KAGAKU KOGYO KK 1981-04-22 JP disclosed
EP-0027377-A1 Derivatives of hydroxyl-bearing substrates, process for their preparation and a method of application Seed, Brian Sarsfield (US) 1981-04-22 EP disclosed
EP-0025339-A1 Microbicidal sulfones, compositions thereof and methods of preparing them UNIROYAL, INC. (US) 1981-03-18 EP disclosed
US-4130661-A ANTICOCCIDIAL MERCK & CO., INC. (US) 1978-12-19 US disclosed
US-4098893-A PYRIDINE DERIVATIVES AND THEIR USE AS ANTICOCCIDIAL AGENTS SANKYO COMPANY LIMITED (JP) 1978-07-04 US disclosed
US-4094982-A PYRIDINE SULFONAMIDES AND THEIR USE AS ANTICOCCIDIAL AGENTS SANKYO COMPANY LIMITED (JA) 1978-06-13 US disclosed
US-4083984-A 1-Substituted phenyl-4(1H)-pyridinone hydrazones and composition therewith for treatment of coccidiosis MERCK & CO., INC. (US) 1978-04-11 US disclosed
US-4079069-A ANTIPROTOZOAL, ANTIPARASITIC MERCK & CO., INC. (US) 1978-03-14 US disclosed
US-4073791-A ANTICOCCIDIAL MERCK & CO., INC. (US) 1978-02-14 US disclosed
US-4054663-A POULTRY FEEDS SANKYO COMPANY LIMITED (JA) 1977-10-18 US disclosed
US-4053608-A 3-NITROPYRIDINE CARBOXAMIDES, POULTRY FEED SANKYO COMPANY LIMITED (JA) 1977-10-11 US disclosed
US-4053602-A POULTRY FEED; ANTIPROTOZOAL, ANTIPARASITIC MERCK & CO., INC. (US) 1977-10-11 US disclosed
US-4044133-A FEED SUPPLEMENT, POULTRY, THIENO-PYRIDINE, OR FURO-PYRIDINE BASE N MERCK & CO., INC. (US) 1977-08-23 US disclosed
US-4006143-A COCCIDIOSTATS MERCK & CO., INC. (US) 1977-02-01 US disclosed
US-3994724-A SUBSTITUTED ANILINE PHOTOCONDUCTOR SCOTT PAPER COMPANY (US) 1976-11-30 US disclosed
US-3991185-A Methods for treating coccidiosis with emimycin and its derivatives MERCK & CO., INC. (US) 1976-11-09 US disclosed
US-3983238-A Substituted pyridinol-containing compositions and methods for the treatment of coccidiosis SANKYO COMPANY LIMITED (JA) 1976-09-28 US disclosed
US-3957997-A Anticoccidial complexes of 4,4'-dinitrocarbanilides MERCK & CO., INC. (US) 1976-05-18 US disclosed
US-3935311-A Substitute pyridinol-containing compositions and methods for the treatment of coccidiosis SANKYO COMPANY LIMITED (JA) 1976-01-27 US disclosed
US-3935311-A Substitute pyridinol-containing compositions and methods for the treatment of coccidiosis SANKYO COMPANY LIMITED (JA) 1976-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (28 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070105832-A1 Substituted azetidinones F2R, CPA3, CFD HSP90AA1 4432/4885TSHR 414/4885LMNA 1127/4885
US-20080182815-A1 Act against several infective agents, and most notably Bacillus spp. and Staphylococcus spp., including infection caused by methicillin-resistant Staphylococcus aureus (MRSA) SQOR, TST, COASY HSP90AA1 427/4885TSHR 4113/4885LMNA 2815/4885
US-20050043408-A1 Anti-glycation agents for preventing age- diabetes- and smoking-related complications AGER, GID4, GALE HSP90AA1 1444/4885TSHR 4241/4885LMNA 509/4885
US-20120122860-A1 SOLID FORMS OF SULFONAMIDES AND AMINO ACIDS BRAF, RAF1, ARAF HSP90AA1 550/4885TSHR 2679/4885LMNA 3902/4885
US-20080139664-A1 ANTI-GLYCATION AGENTS FOR PREVENTING AGE-, DIABETES-, AND SMOKING-RELATED COMPLICATIONS AGER, GID4, GALE HSP90AA1 1439/4885TSHR 4320/4885LMNA 479/4885
US-20160160178-A1 IMMUNOTHERAPY USING STEM CELLS CD14, ICOS, BMP4 HSP90AA1 1615/4885TSHR 1550/4885LMNA 2622/4885
US-20230278965-A1 NOVEL CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS COMPRISING 2 OR MORE ARYL OR HETEROARYL CONNECTED VIA LINKER AND USE THEREOF AADAC, CBR3, MTCL3 HSP90AA1 3895/4885TSHR 4231/4885LMNA 2555/4885
US-20040009979-A1 Use of compounds for the elevation of pyruvate dehydrogenase activity PDHA1, PDK1, PDHB HSP90AA1 483/4885TSHR 3602/4885LMNA 1594/4885
US-20080200496-A1 SUBSTITUTED 1H-PYRROLO[3,2-b, 3,2-c, and 2,3-c]PYRIDINE-2-CARBOXAMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE Ie CSNK1E, CSNK1G3, CSNK2A3 HSP90AA1 4163/4885TSHR 3252/4885LMNA 589/4885
US-20140323463-A1 PYRAZINECARBOXAMIDE COMPOUND EGFR, ERBB2, ALK HSP90AA1 3176/4885TSHR 2449/4885LMNA 4103/4885
US-20150125489-A1 METHOD FOR THE PREPARATION OF DENDRITIC CELL VACCINES CCR7, CD69, CD14 HSP90AA1 622/4885TSHR 4841/4885LMNA 1497/4885
US-20150327547-A1 N-ALKYLTHIO BETA-LACTAMS, ALKYL-COENZYME A ASYMMETRIC DISULFIDES, AND ARYL-ALKYL DISULFIDES AS ANTI-BACTERIAL AGENTS COASY, SQOR, TST HSP90AA1 959/4885TSHR 4071/4885LMNA 2590/4885
US-20100144698-A1 SUBSTITUTED AZETIDINONES F2R, CPA3, CFD HSP90AA1 4432/4885TSHR 414/4885LMNA 1127/4885
US-20090156512-A1 potent activity against resistant pneumococci H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, NAT1, NPM1 HSP90AA1 1581/4885TSHR 1003/4885LMNA 48/4885
US-20020183337-A1 For use in immunosuppression; for reducing the risk of, a reversible obstructive airways disease TPMT, TSLP, TYMP HSP90AA1 3318/4885TSHR 3760/4885LMNA 4754/4885
US-20050131012-A1 Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase lepsilon CSNK2A3, PACSIN2, CSNK1G3 HSP90AA1 4403/4885TSHR 2103/4885LMNA 342/4885
US-20180258036-A1 METHOD FOR PRODUCING BIS(3-AMINOPHENYL)DISULFIDES AND 3-AMINOTHIOLS GSS, QSOX1, SQOR HSP90AA1 947/4885TSHR 3827/4885LMNA 3832/4885
US-20070135511-A1 INDOLE DERIVATIVES USEFUL AS PROGESTERONE RECEPTOR MODULATORS PRLHR, GNRHR, ADCYAP1R1 HSP90AA1 2502/4885TSHR 230/4885LMNA 1228/4885
US-20060252782-A1 Sulfoximine-macrocycle compounds and salts thereof, pharmaceutical compositions comprising said compounds, methods of preparing same and uses of same TEK, FLT1, TIE1 HSP90AA1 4752/4885TSHR 1194/4885LMNA 4670/4885
US-10239831-B2 Method for producing bis(3-aminophenyl)disulfides and 3-aminothiols GSS, QSOX1, SQOR HSP90AA1 947/4885TSHR 3827/4885LMNA 3832/4885
US-20140235565-A1 N-ALKYLTHIO BETA-LACTAMS, ALKYL-COENZYME A ASYMMETRIC DISULFIDES, AND ARYL-ALKYL DISULFIDES AS ANTI-BACTERIAL AGENTS COASY, SQOR, TST HSP90AA1 959/4885TSHR 4071/4885LMNA 2590/4885
US-20090143351-A1 SUBSTITUTED AZETIDINONES F2R, CPA3, CFD HSP90AA1 4432/4885TSHR 414/4885LMNA 1127/4885
US-20060111427-A1 Indole derivatives useful as progesterone receptor modulators PRLHR, GNRHR, ADCYAP1R1 HSP90AA1 2502/4885TSHR 230/4885LMNA 1228/4885
US-20150329485-A1 METHOD FOR PRODUCING BIS(3-AMINOPHENYL)DISULFIDES AND 3-AMINOTHIOLS GSS, QSOX1, SQOR HSP90AA1 947/4885TSHR 3827/4885LMNA 3832/4885
US-20030191142-A1 Thieno[2,3-d]pyrimidinediones, their preparation and use in therapy TYMP, DPYD, TYMS HSP90AA1 2700/4885TSHR 1938/4885LMNA 4234/4885
US-20030198648-A1 Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to HIV-1 RNA MRPS27, SNRPE, NSUN2 HSP90AA1 2171/4885TSHR 4796/4885LMNA 2733/4885
US-10053421-B2 Method for producing bis(3-aminophenyl)disulfides and 3-aminothiols GSS, QSOX1, SQOR HSP90AA1 947/4885TSHR 3827/4885LMNA 3832/4885
US-20030092763-A1 Method for induction of L-selectin shedding PDIA5, PDIA4, PDIA6 HSP90AA1 1036/4885TSHR 4422/4885LMNA 4121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.